Early Introduction of High-Dose Gluten Could Prevent Celiac Disease
New Study at Odds with Previous Research The latest analysis from the Enquiring About Tolerance (EAT) infant food prevention trial demonstrated that very early exposure of high-dose gluten was linked to lower prevalence of celiac disease in 3 year-old children. Celiac disease is occasionally associated with autism. Earlier trials by EAT showed little or no […]
Study Suggests Breastfeeding Protective Against Developing Autism
High Risk Families Should Possibly Consider Nourishing by Breast vs. Bottle In Lebanon, where breastfeeding is declining and autism spectrum disorders (ASD) are increasing, new research has come out which points to more evidence demonstrating that breastfeeding provides a protective effect against the development of autism. This research recruited 46 children under the age of […]
Yogurt Improves Gut Barrier Function
Harvard Study Shows Improvement in Gut Permeability Inflammatory Marker Many individuals with autism have gastrointestinal issues which involve a “leaky gut”, or permeability of the gastrointestinal tract lining. The permeability allows substances to enter the bloodstream such as the inflammatory cytokine, soluble CD14, which is a marker of gut hyperpermeability. A new study looked at […]
Tragic Autism Wandering Case Triggers Change at the FBI
Agent Develops Checklist of Baseline Questions for Missing Children with ASD A North Carolina community was left reeling when the body of a six-year-old boy with autism was discovered in a local park partially submerged in a creek. It was just two years ago when Maddox Ritch wandered off from his family at Gastonia Park. […]
How to Identify and Understand Autism Research
The Autism Research Institute’s New Guide Sifting through scientific and medical autism spectrum disorder studies can be very overwhelming. The Autism Research Institute (ARI) understands this feeling and has recently published a helpful guide for caregivers to interpret and assess research. ARI’s guide provides information like where to find research, descriptions of study types, and […]
Finch Therapeutics Raises $90 Million for Microbiome Medication
Finch Therapeutics Group has raised $90 million to push its oral microbiome drug to treat recurrent C. difficile infection toward a regulatory submission with the FDA. The money raised will also be used to initiate a Phase 1b study evaluating a similar drug for autism spectrum disorder, as well as to advance treatments for chronic hepatitis B infection, ulcerative colitis and Crohn’s disease.
